-
CENTRES
Progammes & Centres
Location
Endocrine-disrupting chemicals are slipping from sewage, through treatment plants, into India’s taps, threatening public health while regulations lag behind.
Image Source: Getty Images
This article is a part of the essay series: World Water Week 2025
Endocrine-disrupting chemicals (EDCs) are exogenous substances that interfere with the standard operation of the hormone (endocrine) system. Biologically, EDCs can mimic hormones, attach to hormone receptors, or otherwise disrupt hormone synthesis, degradation, and signalling. In practical terms, EDCs can usurp the body's chemical messengers and can potentially trigger a cascade of dysfunctions in growth, metabolism, reproduction, and development. Notorious offenders include industrial chemicals such as bisphenol A (BPA) found in plastics, pesticide active ingredients such as DDT (dichlorodiphenyltrichloroethane), medical hormones such as synthetic estrogens, and persistent pollutants such as PFAS (per- and polyfluoroalkyl substances). Yet, in India's water policy and public health debate, EDCs are invisible – unregulated in drinking water standards and largely not even included in routine monitoring.
A growing body of Indian research is detecting various endocrine disruptors in water sources, from rivers and lakes to groundwater, and even treated tap water. These studies, often localised, reveal that EDC contamination is a current reality in India’s water supply chain. Key findings include:
Thus, are these contaminants found in sewage, treated water, or the drinking supply? The answer appears to be all of the above. EDCs can lurk from the raw sewage stage, through partially treated effluents, and all the way to treated drinking water if controls are absent. This pervasive presence in different water system compartments makes EDCs especially insidious.
India's extensive application of pesticides in agriculture makes its rural aquifers and streams vulnerable to contamination by agrochemicals, which are known or suspected endocrine disruptors.
A significant route is via municipal sewage and wastewater effluents. EDCs originate from human excreta (e.g. natural hormones, birth-control residues like ethinylestradiol), pharmaceuticals and personal care products, and household chemicals that get washed down drains. Most Indian wastewater treatment plants are not designed to eliminate micropollutants like EDCs. Studies confirm that conventional WWTPs fail to remove compounds like hormones, triclosan, and phthalates, leading to their “pass-through” into rivers and lakes. India's extensive application of pesticides in agriculture makes its rural aquifers and streams vulnerable to contamination by agrochemicals, which are known or suspected endocrine disruptors. Legacy organochlorine pesticides (such as DDT, aldrin, heptachlor, endosulfan) persist in the soil and migrate into groundwater for decades following application. Even the very pipes and containers used in the distribution of water can contain EDCs.
An often overlooked pathway is also the discharge of hormone drugs, antibiotics, and other bioactive chemicals from pharmaceutical manufacturing units and hospitals. Improper effluent treatment at factories (pharmaceutical industry clusters) can release residues of synthetic hormones (such as progesterone and estradiol used in contraceptives or hormone therapy) and other potent compounds.
India’s regulatory and monitoring frameworks have been largely silent on EDCs in water. The national drinking water standard (BIS IS 10500:2012 specification) and the norms set by the Central Pollution Control Board (CPCB) do not explicitly address most EDCs. A handful of legacy pollutants are covered – for example, BIS prescribes safe limits for a short list of pesticides (like DDT, HCH isomers, and aldrin) and polychlorinated biphenyls (PCBs), as well as some heavy metals. However, critical classes of EDCs such as pharmaceutical hormones, phthalates, BPA, and PFAS are absent from any Indian drinking water standards or routine monitoring requirements. There is no mandate to test tap water or source water for these emerging contaminants.
The Indian regulatory silence on EDCs also means there is minimal pressure on industries and municipal utilities to even measure these pollutants, let alone control them.
By contrast, international standards are rapidly evolving to incorporate EDC considerations. The European Union’s recast Drinking Water Directive (2020) explicitly targets endocrine disruptors and other emerging pollutants. The EU has introduced a watch list mechanism that currently requires member states to monitor two known EDCs – beta-estradiol (a natural estrogen) and nonylphenol (an industrial surfactant) – in their water supplies as an early warning system.
The Indian regulatory silence on EDCs also means there is minimal pressure on industries and municipal utilities to even measure these pollutants, let alone control them. There is also a data gap: very few long-term studies or surveillance programmes exist to quantify EDC levels in water nationwide. The Jabalpur study noted the lack of any baseline data in India for phthalates/BPA in drinking water prior to the authors’ research. Even when troubling findings emerge from academic studies, the response can be dismissive: in Tamil Nadu, authorities denied that Chennai’s water had PFAS issues, citing their own testing. This highlights a need for upgrading our monitoring systems.
India’s battle with EDCs cannot be won by laboratory equipment alone; it needs policies that put everyday drinkers of tap water at the centre of the response. Four practical moves could make that difference.
India’s water pollution challenge has entered a new era. By updating regulations, investing in better water treatment, closely monitoring our water sources, and educating the public, India can reduce the threat of EDCs before it becomes a silent health crisis. This approach will protect the health of our people and also serve as a model for other developing nations facing the same challenge.
K.S. Uplabdh Gopal is an Associate Fellow with the Health Initiative at the Observer Research Foundation.
The views expressed above belong to the author(s). ORF research and analyses now available on Telegram! Click here to access our curated content — blogs, longforms and interviews.
Dr. K. S. Uplabdh Gopal is an Associate Fellow within the Health Initiative at ORF. His focus lies in researching and advocating for policies that ...
Read More +